Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
Crossref DOI link: https://doi.org/10.1007/s00262-014-1580-5
Published Online: 2014-08-07
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Svane, Inge Marie
Verdegaal, Els M.
Text and Data Mining valid from 2014-08-07
